본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Proteogenix

[Proteogenix] Sotrovimab Biosimilar – Anti-Spike glycoprotein mAb – Research Grade

Cat-No. PX-TA1637

Proteogenix는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.

 



제품 설명 


Sotrovimab Biosimilar – Anti-Spike glycoprotein mAb – Research Grade




제품 번호


PX-TA1637




제품 특징


Product nameSotrovimab Biosimilar – Anti-Spike glycoprotein mAb – Research Grade
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA, WB
Aliases /SynonymsSotrovimab ,,Spike glycoprotein,anti-Spike glycoprotein
ReferencePX-TA1637 
NoteFor research use only. Not suitable for human use.
IsotypeHuman IgG
ClonalityMonoclonal Antibody





Data Image

SDS-PAGE for Sotrovimab Biosimilar - Anti-Spike glycoprotein mAb


Sotrovimab Biosimilar - Anti-Spike glycoprotein mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Sotrovimab Biosimilar - Anti-Spike glycoprotein mAb binds to RBD Domain in indirect ELISA Assay


Immobilized RBD Domain (cat. No.PX-COV-P046) at 0.5µg/mL (100µL/well) can bind to Sotrovimab Biosimilar - Anti-Spike glycoprotein mAb (cat. No.PX-TA1637) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450




ProteoGenix의 모든 제품들을 만나보세요!

 

Proteogenix - Official Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"